Francesco Martino. Diagnosis of FH and dyslipidaemia in childhood: the why and how. The therapy?

Size: px
Start display at page:

Download "Francesco Martino. Diagnosis of FH and dyslipidaemia in childhood: the why and how. The therapy?"

Transcription

1 Dipartimento di Pediatria e Neuropsichiatria Infantile Policlinico Umberto I Sapienza Università di Roma Francesco Martino Diagnosis of FH and dyslipidaemia in childhood: the why and how. The therapy?

2 Atherosclerosis is a process that is already detectable in children, even at the fetal stage

3 maternal nutritional imbalances maternal hypercholesterolemia maternal obesity gestational Diabetes smoke Abuse of drugs or alcohol viral infections environmental pollutants Hereditary genetic factors Reprogramming of fetal metabolic gene targets - DNA methylation / inactive chromatin - Histone deacetylation / inactive chromatin -mirna / genes inhibition translation Early cardiovascular risk marckers in infant / child (overweight / obesity - hypertension - dyslipidemia - hyperglycemia - insulin resistance) atherosclerosis

4 Atherosclerosis from childhood to adulthood FASEB J (2002);16: (modified) The cardiovascular risk factors may act at any age dyslipidemia obesity hypertension diabetes sedentary lifestyle (Predominant in adulthood) smoke alcohol stress Family history of premature CVD in relatives of 1st and 2nd degree atheroma rupture of plaque stenosis early fatty streaks fetus fatty streaks children Martino et all. adult atherosclerotic diseases

5 Lipid risk factors for CVD Hypercholesterolemia Hypertriglyceridemia Reduction of HDL High concentrations of apob Small dense LDL Lipoprotein (a)

6 PEDIATRIC DYSLIPIDEMIAS Medication-related dyslipidemia Dyslipidemia related to lifestyle factors Dyslipidemia secondary to a medical condition Genetic dyslipidemia

7 vs. 1/200 Recently direct screening in a Northern European general population diagnosed approximately 1/200 with heterozygous FH. J Clin Endocrinol Metab 2012;97: Endocrinol Metab Clin N Am 43 (2014)

8 In Italy only for 1% of people with heterozygous FH is made a correct diagnosis. European Heart Journal (2013) 34,

9 Pathophysiology of heterozygous FH Elevated LDL col. Only 50% funzional LDLR Mutations (~ 1700) in: LDLR (79%), apolipoprotein B (~5%) PCSK9 (<1%) unidentified genes (5 30%) Atherosclerosis CVD

10 Cardiovascular risk factors Angiotensin II, oxygen radicals, shear stress foam cells NO Oxidative stress OxLDL-C macrophages Endothelial dysfunction

11 cholesterol and Cellular activation in hypercholesterolemic children oxidative stress PLATELETS Martino F et al. scd40l J Am Coll Cardiol (2007); 49 (19): Martino F et al. J Am Coll Cardiol 2007;49: GP91phox Martino F Martino et al. F et al. Pediatrics Pediatrics 2008;122: ;122: Violi F et al. Circulation. 2009;120:

12 MONOCYTES Cellular activation in hypercholesterolemic children cholesterol and Mieloperossidasi P.Pignatelli, L.Loffredo, F. Martino et al. Atherosclerosis. 2009; 205: oxidative stress Down regulation of CD11b and CD18 Martino F. et al. NMCD; 2009;19:

13 0,6 0,5 0,4 0,3 0,2 0,1 0,0 mm IMT * NC HC *p< NC HC Martino F.et all. Pediatrics. 2008;122:e FMD *p< 0.005

14 J Pediatr 2012 Dec;161(6):

15

16 Medicine (Baltimore) Sep;93(12):e71. doi: /MD

17 Medicine (Baltimore) Sep;93(12):e71.

18 need to identify Strategies for Detection of and treat early FH in childhood children and teenagers with dyslipidemia and cascade screening of families using a other risk factors combined phenotypic and genotypic strategy for CVD universal screening selective screening based on family history

19 Survey on cholesterol in childhood Basilicata, Calabria, Lazio TOTAL COLESTEROL (mg/ dl) children (n) children (%) unknown value , ,6 > ,0 school districts in Rome unknown value ,5 npublished data ,3 > ,2

20 Calabrian Sierras Community Study (CSCS) children Blood Pressure are not related to: Blood Lipids

21 TOTAL CHOLESTEROLEMIA An epidemiological study performed on Italian students 19% Calabrian Sierras Community Study (CSCS) children 55% 12% 71% 14% 9% Fondi Study (~200 children) preliminary data 6% 14% up to 170 from 170 to 180 from 180 to 200 over 200 Cholesterolemic values in mg/dl

22 Prevalence of metabolic syndrome Age years MS N total subjects Diagnostic % criteria used for the diagnosis of MS 4,2 4,4 4,7 3,6 4,2 MS based on the percentile distributions: ( 90th for WC, triglycerides, blood M glucose, 43/870 = and 4,9% systolic or diastolic BP F 27/787 = 3,4% and 10th to HDL cholesterol) International Journal of Cardiology 177 (2014)

23 TOTAL CHOLESTEROLEMIA An epidemiological study performed on 750 Italian families PAEDITRIC LIPID CLINIC DEPARTMENT OF PEDIATRICS SAPIENZA UNIVERSITY ROME 20,2 9,9 8,2 18, ,3 50,3 18,8 4,3 PROBANDS up to 170 from 170 to 180 from 180 to 200 from 200 to 300 over 300 2,3 SIBLINGS Cholesterolemic values in mg/dl

24 .three new mutations of the LDLR gene (G266C, T368M and D451Y) have been identified.

25 Editorial Lipid concentrations in children and adolescents: it is not all about obesity

26

27 LIPOPROTEIN CHANGES DURING THE HYPERTRIGLYCERIDEMIA (Pattern B) TG LDL2 lipoproteinlipase LDL3 hepatic lipase TG CETP HDL HDL2 HDL3

28

29

30 The screening of LPL led to identify 8 exonic variants. Most of them have been previously reported, while the p.ser45asn variant is described here for the first time

31 The Mediterranean style as an elixir for CVD prevention PEOPLE HABIT AVOID THE EARLY ADIPOSITY REBOUND ADEQUATE INTAKE: ENERGY,MICRO AND MACRONUTRIENTS intervention strategies PROMOTE BREASTFEEDING WEANING from about J Phys Act Health 2012 Jul;9(5): months of age. Nutr Metab Cardiovasc Dis 2014 Jan;24(1): PUBERTY ADOLESCENCE (plan interventions and education programs for preventing CVD)

32 MEDITERRANEAN DIET RICH IN: deriving from ANTIOXIDANTS SUBSTANCES Fruit Olive oil vegetable Fish (ac.grassi ω3) FIBERS AND FOLIC ACID beans from San Nicola village "Suriaca Russa Janca" COMPLEX CARBOHYDRATES Pasta and bread

33 Poor or less Activity Twice a week LUDIC ACTIVITY ANAEROBIC ACTIVITY AEROBIC ACTIVITIES Bike Swimming Long walks Alternate days Every day ONE HOUR WALK (or more if possible) SPORTS Tennis - Basket Volleyball ecc. go up and down stairs San Nicola Village SCHEDULE of ACTIVITIES

34 breakfast dinner 5 Meals snack in the morning Treatment afternoon for snack lunch Lifestyle modification through exercise and diet remains the front-line treatment for children with abnormal lipid levels dyslipidemic for children older than 2 years children total fat 30% daily calories saturated fat 7-10% MUFA 10% PUFA 10% Protein 15-20% Carbohydrate 50-55% cholesterol limited to mg/day.

35 Fibers that reduce blood cholesterol levels Beet fiber Guar gum Karaya gum Konjac mannan Locust-bean gum Pectin Psyllium seed Soybean polysaccharide Xanthan gum dietary supplementation

36 VISCOSITY OF SOME WATER-SOLUBLE FIBERS GLUCOMANNAN XANTHAN PSYLLIUM 12,0 x 10-1 cp 6,2 x 10-1 cp 2,1 x 10-1 cp Kim E et al.: J Nutr (1996): 29:

37 Glucomannan is not absorbed by the body however it slows down the absorption of carbohydrates and inhibits the absorption of lipids

38

39 Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis Nitesh Sood, Am J Clin Nutr 2008;88:

40

41

42

43

44 Marjet J.A.M et all

45

46 New treatment options to lower LDL cholesterol levels have been testing in randomized clinical trials.

47

48 Take home message Cohort studies show that subclinical atherosclerosis is a progressive disease that arises in childhood and continues through the adulthood. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population. In order to prevent CVD later in life, children with hypercholesterolemia should be identified and treated as early as possible. Lifestyle modification through exercise and diet remains the front-line treatment for children with abnormal lipid levels.

49 Take home message Glucomannan alone or in combination with low-dose chromium-polynicotinate or policosanol was able to significantly reduce total cholesterol and LDL-cholesterol without changing HDL-cholesterol, triglycerides and glucose. When the effects of life-style modification are not sufficient, drug terapy should be considered in boys aged 8 to 10 years or older or girls experiencing menarche

50 Dipartimento di Pediatria e Neuropsichiatria Infantile Policlinico Umberto I Sapienza Università di Roma Thanks for your attention

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien

More information

Lipids. PBHL 211 Darine Hachem, MS, LD

Lipids. PBHL 211 Darine Hachem, MS, LD Lipids PBHL 211 Darine Hachem, MS, LD Outline Functions of lipids in our body Types of lipids Sources of lipids Recommendation of fat intake Fat association with heart diseases Provide energy (9Kcal/g

More information

Cardiovascular Disease Risk Factors:

Cardiovascular Disease Risk Factors: Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood

More information

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids: CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation

More information

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease?

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease? Scott J. Soifer, MD Professor and Vice Chair Department of Pediatrics University of California, San Francisco UCSF Benioff Children s Hospital Cholesterol and Lipids in Kids: It s a Matter of the Heart

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

Chapter 18. Diet and Health

Chapter 18. Diet and Health Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in

More information

Familial hypercholesterolaemia in children and adolescents

Familial hypercholesterolaemia in children and adolescents Familial hypercholesterolaemia in children and adolescents Rationale and recommendations for early identification and treatment European Atherosclerosis Society Consensus Panel Slide deck adapted from:

More information

Nutritional Recommendations for the Diabetes Managements

Nutritional Recommendations for the Diabetes Managements In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful

More information

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of hyperlipidemia. Identify risk factors that lead to the development

More information

Proven and Proposed Cardiovascular Benefits of Soyfoods

Proven and Proposed Cardiovascular Benefits of Soyfoods Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians

Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes

More information

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of

More information

Chapter (5) Etiology of Low HDL- Cholesterol

Chapter (5) Etiology of Low HDL- Cholesterol Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the

More information

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK

More information

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119 Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk

More information

Fiber: What Is It and What Does It Do? By James L. Holly, MD. Your Life Your Health. The Examiner. May 5, 2005

Fiber: What Is It and What Does It Do? By James L. Holly, MD. Your Life Your Health. The Examiner. May 5, 2005 Fiber: What Is It and What Does It Do? By James L. Holly, MD Your Life Your Health The Examiner May 5, 2005 I don t know about you, but fiber has always been a mystery to me. Soluble fiber, insoluble fiber?

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY ALCOHOL NEGATIVE CORRELATION BETWEEN 1-2 DRINKS PER DAY AND THE INCIDENCE OF CARDIOVASCULAR DISEASE SOME HAVE SHOWN THAT EVEN 3-4 DRINKS PER DAY CAN BE BENEFICIAL - WHILE OTHERS HAVE FOUND IT TO BE HARMFUL

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( ) Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80

More information

American Diabetes Association: Standards of Medical Care in Diabetes 2015

American Diabetes Association: Standards of Medical Care in Diabetes 2015 American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform

More information

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Life-long condition Hirsutism Menstrual irregularities? Pronounced

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

3/17/2017. What is Fiber? Fiber and Protein in Your Diet. Fiber Intake Recommendations. Fiber, Satiety, and Weight Relationships.

3/17/2017. What is Fiber? Fiber and Protein in Your Diet. Fiber Intake Recommendations. Fiber, Satiety, and Weight Relationships. What is Fiber? Dietary Fiber consists of nondigestible carbohydrates. Fiber has many roles such as delaying gastric emptying and reducing blood cholesterol concentrations. Fiber and Protein in Your Diet

More information

DYSLIPIDEMIA RECOMMENDATIONS

DYSLIPIDEMIA RECOMMENDATIONS DYSLIPIDEMIA RECOMMENDATIONS Α. DIAGNOSIS Recommendation 1 INITIAL LIPID PROFILING (Level of evidence II) It is recommended to GPs and other PHC Physicians to assess the lipid profile {total cholesterol

More information

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D DYSLIPIDEMIA PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Know normal cholesterol levels Understand what the role

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

OM s Health Corner Cholesterol & Heart Disease!!

OM s Health Corner Cholesterol & Heart Disease!! Cholesterol & Heart Disease!! We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces 75% of the cholesterol that circulates in our blood.

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Prof. John Chapman, MD, PhD, DSc

Prof. John Chapman, MD, PhD, DSc Prof. John Chapman, MD, PhD, DSc Director of the Dyslipidemia and Atherosclerosis Research Unit of the National Institute for Health and Medical Research (INSERM) at the Pitié-Salpétrière Hospital in Paris

More information

CHOLESTEROL CONTENT CREATED BY. Learn more at

CHOLESTEROL CONTENT CREATED BY. Learn more at CHOLESTEROL CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents what is cholesterol? 4 Whether this is your first visit or a follow-up, asking your doctor these

More information

Five chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical

More information

Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm

Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm Authors: Julie Lanigan, Lisa Cooke and Clare Stradling Date of Preparation: September 2010 Date reviewed: October

More information

Arteriosclerosis & Atherosclerosis

Arteriosclerosis & Atherosclerosis Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,

More information

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal

More information

Maintain Cholesterol

Maintain Cholesterol Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured

More information

Medical Nutrition Therapy Options for Adults Living with Diabetes. Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services

Medical Nutrition Therapy Options for Adults Living with Diabetes. Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services Medical Nutrition Therapy Options for Adults Living with Diabetes Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services Objectives Discuss Medical Nutrition Therapy considerations

More information

Health Score SM Member Guide

Health Score SM Member Guide Health Score SM Member Guide Health Score Your Health Score is a unique, scientifically based assessment of seven critical health indicators gathered during your health screening. This number is where

More information

Cholesterol Levels -- What They Mean, Diet and Treatment

Cholesterol Levels -- What They Mean, Diet and Treatment Cholesterol Levels -- What They Mean, Diet and Treatment What Is Cholesterol? We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces

More information

LIPID CLUB Rome, 2014

LIPID CLUB Rome, 2014 LIPID CLUB Rome, 2014 June the 6h 6th Hyperlipidaemia in FH Children Ornella Guardamagna University of Torino DICLOSURES Medpace Kowa DSMB member MSD, Pfizer, Synageva Investigator in industry funded trials

More information

Case Study #4: Hypertension and Cardiovascular Disease

Case Study #4: Hypertension and Cardiovascular Disease Helen Jang Tara Hooley John K Rhee Case Study #4: Hypertension and Cardiovascular Disease 7. What risk factors does Mrs. Sanders currently have? The risk factors that Mrs. Sanders has are high blood pressure

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP What is Heart Disease Cardiovascular Disease (CVD): Heart or Blood vessels are not working properly. Most common reason

More information

Where are we heading?

Where are we heading? Unit 5: Where are we heading? Unit 5: Introduction Unit 1: What s in your food? Unit 2: How does your body use food? Unit 3: What is metabolic disease? Unit 4: How do I identify good and bad food? Unit

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes

More information

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular

More information

PhysicsAndMathsTutor.com. Question Number 1(a) Answer Additional Guidance Mark NB any sign of an arrow then item to go to review. 1.

PhysicsAndMathsTutor.com. Question Number 1(a) Answer Additional Guidance Mark NB any sign of an arrow then item to go to review. 1. 1(a) NB any sign of an arrow then item to go to review. 1. platelets 2. prothrombin 1. ACCEPT plattelets, platellets 2. ACCEPT prothrombrin 3. fibrin 1(b) 1. prevents oxygen reaching the heart {muscle

More information

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only

More information

HEÆRT HEÆLTH. Cardiovascular disease is

HEÆRT HEÆLTH. Cardiovascular disease is Cardiovascular disease is the term for several diseases which include high blood pressure, stroke, Coronary Heart Disease (CHD) and others. For this lesson we will address CHD, the leading cause of death

More information

Lipids Types, Food Sources, Functions

Lipids Types, Food Sources, Functions Lipids Types, Food Sources, Functions What Are Lipids? Lipids Diverse group of molecules that are insoluble in water Fats The lipid content of diets and foods 1 Lipids in Body Cells and Tissues Types of

More information

Prevention and Management Of Obesity Adolescents & Children

Prevention and Management Of Obesity Adolescents & Children Prevention and Management Of Obesity Adolescents & Children The Pediatric Obesity Prevention and Treatment Toolkit is available at: https://www.optimahealth.com/providers/clinical-reference/pediatric-obesity-prevention-andtreatment-toolkit

More information

Blood Pressure Measurement (children> 3 yrs)

Blood Pressure Measurement (children> 3 yrs) Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University

More information

NUTRITION J E S Ú S A L C Á N T A R A R U I Z

NUTRITION J E S Ú S A L C Á N T A R A R U I Z NUTRITION J E S Ú S A L C Á N T A R A R U I Z TABLE OF CONTENTS 1. Nutrition & Alimentation 2. Nutrients 3. Balanced diet 4. The importance of having breakfast 5. Nutrition for teenagers 6. Malnutrition

More information

Disclosures. Pediatric Dyslipidemia Casey Elkins, DNP, NP C, CLS, FNLA. Learning Objectives. Atherogenesis. Acceptable Values

Disclosures. Pediatric Dyslipidemia Casey Elkins, DNP, NP C, CLS, FNLA. Learning Objectives. Atherogenesis. Acceptable Values 39 th National Conference on Pediatric Health Care Pediatric Dyslipidemia Casey Elkins, DNP, NP C, CLS, FNLA March 19-22, 2018 CHICAGO Disclosures Speakers Bureau Sanofi and Regeneron Learning Objectives

More information

Contributions of diet to metabolic problems in survivors of childhood cancer

Contributions of diet to metabolic problems in survivors of childhood cancer Contributions of diet to metabolic problems in survivors of childhood cancer Kim Robien, PhD, RD, CSO, FAND Department of Exercise and Nutrition Sciences Milken Institute School of Public Health George

More information

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean

More information

NAME/ID: SAMPLE PATIENT SEX: FEMALE ACC #: F DATE: NOV 12, 2015 IMPORTANT INFORMATION

NAME/ID: SAMPLE PATIENT SEX: FEMALE ACC #: F DATE: NOV 12, 2015 IMPORTANT INFORMATION Personal Details Name: SAMPLE PATIENT DOB: Jan 1, 19XX Gender: Female Ethnicity: Caucasian Report Date: Nov 12, 2015 Received Date: Nov 2, 2015 IMPORTANT INFORMATION PAGE 3 Test Performed / Method Genotyping

More information

Zuhier Awan, MD, PhD, FRCPC

Zuhier Awan, MD, PhD, FRCPC Metabolism, Atherogenic Properties and Agents to Reduce Triglyceride-Rich Lipoproteins (TRL) The Fifth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 8-11, 2019 Zuhier

More information

Metabolic Syndrome.

Metabolic Syndrome. www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present

More information

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise

More information

Dash to Heart Health. Elizabeth Bergman, R.D, LD/N Clinical Dietitian Memorial Regional Hospital

Dash to Heart Health. Elizabeth Bergman, R.D, LD/N Clinical Dietitian Memorial Regional Hospital Dash to Heart Health Elizabeth Bergman, R.D, LD/N Clinical Dietitian Memorial Regional Hospital Objectives 1. Identify nutrition-related risk factors for CVD 2. Treat CVD with heart healthy foods 3. List

More information

Future directions for nutritional and therapeutic research in omega-3 3 lipids

Future directions for nutritional and therapeutic research in omega-3 3 lipids Future directions for nutritional and therapeutic research in omega-3 3 lipids Philip Calder Professor of Nutritional Immunology University of Southampton Aim To review dietary sources and intakes of long

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

Dr G R Letchuman. Clogged by Cholesterol

Dr G R Letchuman. Clogged by Cholesterol Dr G R Letchuman Clogged by Cholesterol Main message Cholesterol management is all about reducing risk of CV events vs the side effects, hassle and cost of drugs News that it is no longer important to

More information

Health benefits of cereal foods and components in our daily diet - an overview Gabriele Riccardi, MD, FAHA

Health benefits of cereal foods and components in our daily diet - an overview Gabriele Riccardi, MD, FAHA Health benefits of cereal foods and components in our daily diet - an overview Gabriele Riccardi, MD, FAHA Full Professor of Endocrinology and Metabolic Diseases Director of the Master Course on Human

More information

Low carbohydrate diets- do they have a place?

Low carbohydrate diets- do they have a place? Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Controlling your risk factors WE RECOMMEND THAT YOU Monitor your blood pressure on a regular basis If you have high blood pressure, reduce your intake of salt, tea and coffee Drink

More information

Fats and Other Lipids

Fats and Other Lipids Fats and Other Lipids Chapter 6 Chapter 6: Fats and other Lipids 1 6.1 Understanding Lipids Lipids include: 1. Fatty acids 2. Triglycerides 3. Phospholipids 4. Cholesterol Oil and Water Don t Mix Because

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information

Victor Tambunan. Department of Nutrition Faculty of Medicine Universitas Indonesia

Victor Tambunan. Department of Nutrition Faculty of Medicine Universitas Indonesia Victor Tambunan Department of Nutrition Faculty of Medicine Universitas Indonesia 1 Handbook of Clinical Nutrition 4th ed., 2006, by D. C. Heimburger & J. A. Ard Krause s Nutrition & Diet Therapy 12th

More information

Principles of Management. Dietary Management of Diabetes mellitus. Goals with dietary intervention. Dietary management. Atkins diet (Low CHO)

Principles of Management. Dietary Management of Diabetes mellitus. Goals with dietary intervention. Dietary management. Atkins diet (Low CHO) Dietary Management of Diabetes mellitus Principles of Management Diabetes mellitus Marlene Gilfillan Medical treatment Exercise Diet Goals with dietary intervention Decrease HbA1c Losing weight Balancing

More information

Diabetes: Prevention and Maintenance

Diabetes: Prevention and Maintenance Presented by Diabetes: Prevention and Maintenance Dirker Chiropractic 909 S. Taylor Dr. 920-451-7000 10/7/2013 Eating, Exercise, Energy & Metabolism Food is fuel for energy, vitality and health The glycemic

More information

Appendix G. U.S. Nutrition Recommendations and Guidelines. Dietary Guidelines for Americans, Balancing Calories to Manage Weight

Appendix G. U.S. Nutrition Recommendations and Guidelines. Dietary Guidelines for Americans, Balancing Calories to Manage Weight Appendix G U.S. Nutrition Recommendations and Guidelines Dietary Guidelines for Americans, 2010 Balancing Calories to Manage Weight Prevent and/or reduce overweight and obesity through improved eating

More information

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia

More information

Chest pain affects 20% to 40% of the general population during their lifetime.

Chest pain affects 20% to 40% of the general population during their lifetime. Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a

More information

Staying Healthy with Diabetes

Staying Healthy with Diabetes Staying Healthy with Diabetes Note to the Health Care Provider: Topics in this handout are discussed in Chapters 6 and 13 of the American Dietetic Association Guide to Diabetes Medical Nutrition Therapy

More information

Your Name & Phone Number Here! Longevity Index

Your Name & Phone Number Here! Longevity Index Your Name & Phone Number Here! Longevity Index Your Health Risk Analysis is based on a variety of medical and scientific data from organizations such as the American Heart Association, American Dietetic

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Cardiac patient quality of life. How to eat adequately?

Cardiac patient quality of life. How to eat adequately? Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension

More information

Young high risk patients the role of statins Dr. Mohamed Jeilan

Young high risk patients the role of statins Dr. Mohamed Jeilan Young high risk patients the role of statins Dr. Mohamed Jeilan KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures

More information

Attaining optimal weight getting the balance right. A/Professor Manny Noakes CSIRO FOOD AND NUTRITIONAL SCIENCES

Attaining optimal weight getting the balance right. A/Professor Manny Noakes CSIRO FOOD AND NUTRITIONAL SCIENCES Attaining optimal weight getting the balance right A/Professor Manny Noakes CSIRO FOOD AND NUTRITIONAL SCIENCES Metabolic consequences of excess weight Obesity and Disease Risk in Australia Relative disease

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC Hypertriglyceridemia: Why, When, and How to Treat Gregory Cohn, MD, FNLA, FASPC DISCLOSURES Consultant to Akcea Therapeutics (in the past 12 months). OUTLINE I. Lipoproteins II. Non-HDL-C III. Causes and

More information

Familial hypercholesterolaemia

Familial hypercholesterolaemia Familial hypercholesterolaemia Jaimini Cegla MRCP FRCPath PhD Consultant in Chemical Pathology and Metabolic Medicine Hammersmith Hospital Lipid Clinic 20 April 2017 An unrecognised, potentially fatal,

More information

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global

More information

KEY INDICATORS OF NUTRITION RISK

KEY INDICATORS OF NUTRITION RISK NUTRITION TOOLS KEY INDICATORS OF Consumes fewer than 2 servings of fruit or fruit juice per day. Consumes fewer than 3 servings of vegetables per day. Food Choices Fruits and vegetables provide dietary

More information

Insert logo. Linda Main, Dietetic Adviser

Insert logo. Linda Main, Dietetic Adviser Insert logo Linda Main, Dietetic Adviser HEART UK The Cholesterol Charity Our Vision: To prevent avoidable and early deaths caused by high cholesterol. We want the majority of UK adults to know their cholesterol

More information

Lipid Metabolism in Familial Hypercholesterolemia

Lipid Metabolism in Familial Hypercholesterolemia Lipid Metabolism in Familial Hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis

More information

Genetic and biochemical characteristics of patients with hyperlipidemia who require LDL apheresis

Genetic and biochemical characteristics of patients with hyperlipidemia who require LDL apheresis Genetic and biochemical characteristics of patients with hyperlipidemia who require LDL apheresis Mato Nagel, Ioan Duma, Constantina Vlad, Mandy Benke, Sylvia Nagorka Zentrum für Nephrologie & Stoffwechsel,

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACC/AHA. See American College of Cardiology/ ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors American College of Cardiology/American

More information

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,

More information